Search for: "Matter of Noonan"
Results 101 - 120
of 304
Sorted by Relevance
|
Sort by Date
17 Apr 2019, 9:59 pm
Noonan -- Over the past six years, since the Supreme Court handed down its decision in Mayo Collaborative Services, Inc. v. [read post]
17 Mar 2020, 9:55 pm
Noonan -- The latest Federal Circuit decision on subject matter eligibility in the life sciences came down (by a divided court) in favor of eligibility, in Illumina, Inc. v. [read post]
7 Sep 2016, 9:59 pm
Noonan -- Perhaps one of the most influential first year law school classes for the task of learning how to "think like a lawyer" is civil procedure. [read post]
22 Sep 2016, 8:38 pm
Noonan -- Before the Supreme Court's recent forays into the topic of subject matter eligibility in patent law, the most contentious line of cases (from the Federal Circuit) concerned the written description requirement of Section 112. [read post]
19 May 2015, 9:59 pm
Noonan -- The Federal Circuit affirmed a decision by the U.S. [read post]
18 Jul 2023, 8:36 pm
Noonan -- For at least a decade, Congress has been concerned (not to say obsessed) with drug costs (understandably so, no matter how ineffective; see "FTC to the Rescue Regarding High Drug Prices and Patents"; "Even More Ill-Conceived Remedies from Congress Regarding Prescription Drug Costs"; "More Ill-conceived Remedies from Congress Regarding Prescription Drug Costs"; "A Solution in Search of a Problem"; Senate Once Again Tries to Address… [read post]
6 Jul 2016, 9:44 pm
Noonan -- As we have had the occasion to say before regarding subject matter eligibility, "[o]ne swallow does not a summer make, nor one fine day . . . [read post]
9 Aug 2020, 9:37 pm
The Court followed this practice in what is perhaps its most confusing and controversial application of the Supreme Court's subject matter eligibility jurisprudence under Alice Corp. [read post]
14 Mar 2021, 9:07 pm
Noonan -- The Federal Circuit affirmed a decision by the U.S. [read post]
12 Oct 2020, 9:59 pm
The Commission has not lost its enthusiasm for such interventions in drug patenting matters but without (so far) overwhelming success. [read post]
20 Feb 2013, 9:59 pm
The matter below involved purported... [read post]
16 Nov 2021, 9:59 pm
Noonan -- The Federal Circuit continued its stringent (if misguided) application of the scope of subject matter eligibility by invalidating claims asserted in CardioNet, LLC v. [read post]
15 May 2023, 8:13 am
Noonan -- Today, the Supreme Court again disregarded the views of the Federal government regarding whether to grant certiorari, here in Teva Pharmaceuticals USA v. [read post]
15 Feb 2022, 9:03 pm
Noonan -- The 2020 decision by a divided Federal Circuit panel in GlaxoSmithKline LLC v. [read post]
30 Jan 2014, 9:59 pm
Noonan -- Earlier this week, Sequenom, Inc. filed its opening brief in Ariosa Diagnostics, Inc. v. [read post]
14 Jun 2012, 9:59 pm
Noonan -- Last year, the Australian Senate rejected a call for banning patents on human genes in Australia. [read post]
7 Feb 2014, 2:37 pm
Noonan -- Gene-by-Gene, Inc. was one of the first direct-to-consumer (DTC) genetic diagnostics companies to announce that it would offer BRCA1/BRCA2 testing after the Supreme Court's decision last June that certain of Myriad Genetics' claims (those that encompassed isolated genomic DNA) were invalid for reciting patent-ineligible subject matter. [read post]
3 Aug 2020, 9:59 pm
Noonan -- Earlier this year, the Federal Circuit (somewhat surprisingly) found claims of two Sequenom patents directed to methods for detecting fetal DNA in maternal blood to satisfy the subject matter eligibility requirements of Section 101 (see "Illumina, Inc. v. [read post]
4 Mar 2021, 8:06 pm
Noonan -- On March 1st, the U.S. [read post]
15 Jun 2022, 8:43 pm
Noonan -- On May 23rd, U.S. [read post]
